www.fdanews.com/articles/152754-baxter-to-acquire-investigational-hemophilia-compound-and-related-assets

Baxter to Acquire Investigational Hemophilia Compound and Related Assets

January 29, 2013

Baxter International has entered into an agreement to acquire Inspiration BioPharmaceuticals’ investigational hemophilia compound OBI-1 and related assets.
Pharmaceutical Business Review